Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed7
Recruiting1
Other1

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT06072703Not ApplicableRecruiting
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Multiple SclerosisNeurogenic BladderOveractive Bladder
PrincipalinvestigatorStart date: 2023-10-30
NCT05652036Phase 4Completed
Procedural Discomfort Related to Number of Intradetrusor Botox Injections
Overactive Bladder
PrincipalinvestigatorStart date: 2022-07-07
NCT03817931Phase 4Completed
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
DementiaIncontinence, UrgeLower Urinary Tract Symptoms+1 more
PrincipalinvestigatorStart date: 2019-08-05
NCT03991429Completed
Brain Imaging in Men With Lower Urinary Tract Symptoms
Voiding Disorders
PrincipalinvestigatorStart date: 2019-06-04
NCT03574610Not ApplicableCompleted
Brain Targets in Patients With Bladder Emptying Difficulties
Multiple SclerosisNeurogenic BladderVoiding Dysfunction
PrincipalinvestigatorStart date: 2018-07-01
NCT03202251Completed
Deep Brain Stimulation in Patients With LUTS
Bladder DysfunctionNeurogenic Bladder
PrincipalinvestigatorStart date: 2017-04-11
Prospective Cohort of Transitional Urology Patients
Bladder ExstrophyCloacal ExstrophyGenitourinary Congenital Anomalies+3 more
PrincipalinvestigatorStart date: 2015-08-27
NCT03033355Completed
Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder
Detrusor, OveractiveLower Urinary Tract SymptomsMultiple Sclerosis+2 more
PrincipalinvestigatorStart date: 2014-02-01

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jill Danford, MD

Baylor Scott and White Health

Moderately Similar
1 trials

Shared therapeutic areas:

DementiaUrinary Incontinence, UrgeLower Urinary Tract Symptoms+1 more

Worked with same sponsors:

Baylor Research InstituteInternational Urogynecological Association+1 more
Collaborated on 1 trial
Similarity Score44%

Rachel High, DO

Baylor Scott and White Health

Moderately Similar
2 trials

Shared therapeutic areas:

Lower Urinary Tract SymptomsDementiaUrinary Incontinence, Urge+1 more

Worked with same sponsors:

Baylor Research InstituteInternational Urogynecological Association+1 more
Collaborated on 1 trial
Similarity Score44%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

HealthyDementiaMultiple Sclerosis
Similarity Score5%

Mikhail Samsonov

R-Pharm

Related
34 trials

Shared therapeutic areas:

HealthyMultiple SclerosisUrinary Bladder, Overactive
Similarity Score5%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Multiple SclerosisHealthy
Similarity Score4%

Ken Nedd, M.D.

GAAD Medical Research Institute Inc.

Related
20 trials

Shared therapeutic areas:

DementiaMultiple Sclerosis
Similarity Score4%

Rachel Pauls, MD

TriHealth - Cincinnati Urogynecology Associates

Related
21 trials

Shared therapeutic areas:

Urinary Bladder, OveractiveUrinary Incontinence, Urge
Similarity Score4%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score2%

Waqar ahmed awan, Phd

Riphah International University

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score2%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT06072703Not ApplicablePrincipalInvestigator

Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS

Multiple SclerosisNeurogenic BladderOveractive Bladder
Recruiting
NCT05652036Phase 4PrincipalInvestigator

Procedural Discomfort Related to Number of Intradetrusor Botox Injections

Overactive Bladder
Completed
NCT04846387PrincipalInvestigator

Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study

Healthy
Completed
NCT03817931Phase 4PrincipalInvestigator

Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

DementiaIncontinence, UrgeLower Urinary Tract Symptoms+1 more
Completed
NCT03991429PrincipalInvestigator

Brain Imaging in Men With Lower Urinary Tract Symptoms

Voiding Disorders
Completed
NCT03574610Not ApplicablePrincipalInvestigator

Brain Targets in Patients With Bladder Emptying Difficulties

Multiple SclerosisNeurogenic BladderVoiding Dysfunction
Completed
NCT03202251PrincipalInvestigator

Deep Brain Stimulation in Patients With LUTS

Bladder DysfunctionNeurogenic Bladder
Completed
NCT03061084PrincipalInvestigator

Prospective Cohort of Transitional Urology Patients

Bladder ExstrophyCloacal ExstrophyGenitourinary Congenital Anomalies+3 more
Unknown
NCT03033355PrincipalInvestigator

Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder

Detrusor, OveractiveLower Urinary Tract SymptomsMultiple Sclerosis+2 more
Completed

All 9 trials loaded